Latest Security News

Energy Transition Minerals Ltd has issued a prospectus offering up to 68.75 million free-attaching quoted options to placement participants as part of a $9.35 million capital raising. The options, exercisable at $0.12 and expiring in 18 months, aim to support expansion in Greenland and project development despite ongoing litigation risks.

SIV Capital Limited reported a negative operating cash flow for Q2 FY25 and remains suspended from ASX trading due to compliance issues, while actively exploring acquisition opportunities.

Perpetual Resources reports significant assay results confirming ultra-high grade spodumene at its Isabella Lithium Project and initiates metallurgical testing at the Raptor Rare Earth Project, backed by a strategic MOU with Minas Gerais government and a $1 million capital raise.

Key Petroleum Limited progresses Potential Commercial Area applications for ATPs 920 and 924 in Queensland’s Cooper Eromanga Basin, supported by a recent capital raise despite a constrained cash balance.

Oneview Healthcare reported a robust Q4 2024 cash flow update, bolstered by a significant equity raise and expanding partnerships, positioning the company for accelerated growth in 2025.

VDM Group Limited faces a complex ownership dispute over its Angolan projects, leading to halted exploration and a prolonged ASX trading suspension. Meanwhile, the company is actively pursuing new critical minerals opportunities in Australia to revive its operations.

Auswide Bank has secured Treasurer approval for MyState Bank’s acquisition via a scheme of arrangement, setting the stage for a pivotal shareholder vote in early February.

MyState Limited has secured Federal Treasurer approval for its merger with Auswide Bank, advancing plans to create a larger regional banking group pending shareholder and court consent.

ENRG Elements Limited reported a $586,000 net cash outflow for the December quarter, offset by a $2.02 million equity raise, boosting its cash reserves to $2.52 million.

ENRG Elements Limited has renewed key uranium exploration permits in Niger and reported outstanding trenching assay results, while securing $2.2 million in new funding to advance its projects.

Astron Corporation has responded to ASX concerns over a delayed Appendix 3Y filing, attributing the lag to director travel and reaffirming its compliance protocols.

InhaleRx has corrected its quarterly report and revealed a $38.5 million funding deal to fast-track clinical trials for its inhaled therapies targeting breakthrough cancer pain and panic disorder, aiming for FDA approval.